Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by ROSSER, W. W
Right arrow Articles by FRAME, P. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSSER, W. W
Right arrow Articles by FRAME, P. S
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Family Practice Vol. 10, No. 4, 431-438
© Oxford University Press 1993

research-article

An International Perspective on the Cholesterol Debate

WALTER W ROSSER*,, WILFRED H PALMER*, GODFREY FOWLER**, HANK LAMBERTS{dagger}, ALEX THOMSON{ddagger}, CINDY LAM and PAUL S FRAME||

* University of Toronto
** University of Oxford
{dagger} University of Amsterdam
{ddagger} University of Auckland
University of Hong Kong
|| University of Rochester

Correspondence and reprints to Dr Walter W Rosser, Department of Family and Community Medicine. University of Toronto, 620 University Avenue 8th Floor, Toronto, Ontario, Canada M5G 2C1

For the past 5 years there has been an intensive debate and a number of conflicting guidelines suggesting what general practitioners (GPs) should do to screen and manage hyperlipidaemia. At a WONCA seminar in Vancouver in 1992, policies and guidelines from Canada, the UK, The Netherlands, New Zealand, Hong Kong and the USA were reviewed. It was concluded that cholesterol policy and guidelines tend to be influenced more by political and economic factors than by evidence of health benefit. International guidelines for cholesterol screening and management would be of minimal value, as GPs would have to interpret the epidemiological evidence of benefit from lipid screening and lipid lowering strategy in the context of each patient to arrive at optimum management.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Fam PractHome page
P. J van den Berg, C. L van Dalsen, R. A. de Rooij, A. Prins, and A. W Hoes
Cardiovascular health check in the elderly in one general practice: does it offer new information and lead to interventions?
Fam. Pract., August 1, 1999; 16(4): 389 - 394.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.